Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xaviar M Jones

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Rheumatology (Oxford, England)|November 26, 2025
Risk of heart failure in systemic sclerosis: is it more than just ischemic heart disease?Xaviar M Jones, Attila Feher
Trends in Cardiovascular Medicine|December 3, 2023
Editorial commentary: Ablation and appendage occlusion for atrial fibrillation: Does it take two to tango?Xaviar M Jones, Eugenio Cingolani
Journal of Scleroderma and Related Disorders|January 23, 2025
Cardiac involvement in systemic sclerosis: A critical review of knowledge gaps and opportunitiesXaviar M Jones, Nunzio Bottini, Francesco Boin, et al.
JACC. Basic to Translational Science|April 30, 2025
Reply: Macrophage Activation in Systemic SclerosisXaviar M Jones, Salwa Soussi, Nunzio Bottini, et al.
JCI Insight|January 29, 2026
Small noncoding RNA TY2 enhances efferocytosis and improves outcomes in a mouse model of sepsisAlessandra Ciullo, Xaviar M Jones, Hiroaki Komuro, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Oral bioavailability of a noncoding RNA drug, TY1, that acts on macrophagesShukuro Yamaguchi, Kazutaka Miyamoto, Xaviar M Jones, et al.
JACC. Basic to Translational Science|January 17, 2025
Macrophages Contribute to Cardiac Fibrosis and Diastolic Dysfunction in Systemic SclerosisXaviar M Jones, Russell G Rogers, Kara Tsi, et al.
Basic Research in Cardiology|December 31, 2024
Intravenous and oral administration of the synthetic RNA drug, TY1, reverses heart failure with preserved ejection fraction in miceKazutaka Miyamoto, Xaviar M Jones, Shukuro Yamaguchi, et al.
Nature Communications|January 30, 2025
Upregulated FoxO1 promotes arrhythmogenesis in mice with heart failure and preserved ejection fractionThassio Mesquita, Rodrigo Miguel-Dos-Santos, Weixin Liu, et al.
Journal of Extracellular Biology|August 18, 2025
Oral Bioavailability of a Noncoding RNA Drug, TY1, That Acts on MacrophagesShukuro Yamaguchi, Kazutaka Miyamoto, Xaviar M Jones, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Rheumatology (Oxford, England)|November 26, 2025
Risk of heart failure in systemic sclerosis: is it more than just ischemic heart disease?Xaviar M Jones, Attila Feher
Trends in Cardiovascular Medicine|December 3, 2023
Editorial commentary: Ablation and appendage occlusion for atrial fibrillation: Does it take two to tango?Xaviar M Jones, Eugenio Cingolani
Journal of Scleroderma and Related Disorders|January 23, 2025
Cardiac involvement in systemic sclerosis: A critical review of knowledge gaps and opportunitiesXaviar M Jones, Nunzio Bottini, Francesco Boin, et al.
JACC. Basic to Translational Science|April 30, 2025
Reply: Macrophage Activation in Systemic SclerosisXaviar M Jones, Salwa Soussi, Nunzio Bottini, et al.
JCI Insight|January 29, 2026
Small noncoding RNA TY2 enhances efferocytosis and improves outcomes in a mouse model of sepsisAlessandra Ciullo, Xaviar M Jones, Hiroaki Komuro, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Oral bioavailability of a noncoding RNA drug, TY1, that acts on macrophagesShukuro Yamaguchi, Kazutaka Miyamoto, Xaviar M Jones, et al.
JACC. Basic to Translational Science|January 17, 2025
Macrophages Contribute to Cardiac Fibrosis and Diastolic Dysfunction in Systemic SclerosisXaviar M Jones, Russell G Rogers, Kara Tsi, et al.
Basic Research in Cardiology|December 31, 2024
Intravenous and oral administration of the synthetic RNA drug, TY1, reverses heart failure with preserved ejection fraction in miceKazutaka Miyamoto, Xaviar M Jones, Shukuro Yamaguchi, et al.
Nature Communications|January 30, 2025
Upregulated FoxO1 promotes arrhythmogenesis in mice with heart failure and preserved ejection fractionThassio Mesquita, Rodrigo Miguel-Dos-Santos, Weixin Liu, et al.
Journal of Extracellular Biology|August 18, 2025
Oral Bioavailability of a Noncoding RNA Drug, TY1, That Acts on MacrophagesShukuro Yamaguchi, Kazutaka Miyamoto, Xaviar M Jones, et al.
Pageof 2